相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled phase II dose-ranging study
K. A. Papp et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
Primary progressive multiple sclerosis: part of the MS disease spectrum or separate disease entity?
Jack Antel et al.
ACTA NEUROPATHOLOGICA (2012)
Psoriasis: rationale for targeting interleukin-17
G. Girolomoni et al.
BRITISH JOURNAL OF DERMATOLOGY (2012)
Secukinumab induction and maintenance therapy in moderate-to-severe plaque psoriasis: a randomised, double-blind, placebo-controlled, phase II regimen-finding study
P. Rich et al.
BRITISH JOURNAL OF DERMATOLOGY (2012)
Protective effect of an elastase inhibitor in a neuromyelitis optica-like disease driven by a peptide of myelin oligodendroglial glycoprotein
Katja Herges et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course
Mohsen Khademi et al.
MULTIPLE SCLEROSIS JOURNAL (2011)
Oligodendrocytes are damaged by neuromyelitis optica immunoglobulin G via astrocyte injury
Romain Marignier et al.
BRAIN (2010)
Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice
Samira Saadoun et al.
BRAIN (2010)
Contribution of Astrocyte-Derived IL-15 to CD8 T Cell Effector Functions in Multiple Sclerosis
Philippe Saikali et al.
JOURNAL OF IMMUNOLOGY (2010)
Cytokine and chemokine profiles in neuromyelitis optica: significance of interleukin-6
Akiyuki Uzawa et al.
MULTIPLE SCLEROSIS JOURNAL (2010)
T helper type 1 and 17 cells determine efficacy of interferon-β in multiple sclerosis and experimental encephalomyelitis
Robert C. Axtell et al.
NATURE MEDICINE (2010)
IFNβ-1b may severely exacerbate Japanese optic-spinal MS in neuromyelitis optica spectrum
J. Shimizu et al.
NEUROLOGY (2010)
Neuromyelitis Optica: Pathogenicity of Patient Immunoglobulin In Vivo
Monika Bradl et al.
ANNALS OF NEUROLOGY (2009)
Intrathecal Pathogenic Anti-Aquaporin-4 Antibodies in Early Neuromyelitis Optica
Jeffrey L. Bennett et al.
ANNALS OF NEUROLOGY (2009)
Aquaporin-4 autoimmune syndrome and anti-aquaporin-4 antibody-negative opticospinal multiple sclerosis in Japanese
T. Matsushita et al.
MULTIPLE SCLEROSIS JOURNAL (2009)
Pathologic and immunologic profiles of a limited form of neuromyelitis optica with myelitis
K. Yanagawa et al.
NEUROLOGY (2009)
Neuromyelitis Optica and non-organ-specific Autoimmunity
Sean J. Pittock et al.
ARCHIVES OF NEUROLOGY (2008)
Isolation and characterization of CD8+ regulatory T cells in multiple sclerosis
Jorge Correale et al.
JOURNAL OF NEUROIMMUNOLOGY (2008)
Distinct CSF cytokine/chemokine profiles in atopic myelitis and other causes of myelitis
M. Tanaka et al.
NEUROLOGY (2008)
Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis
Shanu F. Roemer et al.
BRAIN (2007)
Interferon beta-1b exacerbates multiple sclerosis with severe optic nerve and spinal cord demyelination
Yoko Warabi et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2007)
Revised diagnostic criteria for neuromyelitis optica
D. M. Wingerchuk et al.
NEUROLOGY (2006)
IL-15 is elevated in serum and cerebrospinal fluid of patients with multiple sclerosis
M Rentzos et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2006)
Diagnostic criteria for multiple sclerosis: 2005 Revisions to the McDonald Criteria
CH Polman et al.
ANNALS OF NEUROLOGY (2005)
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
H Park et al.
NATURE IMMUNOLOGY (2005)
Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages
LE Harrington et al.
NATURE IMMUNOLOGY (2005)
IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel
VA Lennon et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Intrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosis
T Ishizu et al.
BRAIN (2005)
CSF chemokine levels in relapsing neuromyelitis optica and multiple sclerosis
K Narikawa et al.
JOURNAL OF NEUROIMMUNOLOGY (2004)
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
VA Lennon et al.
LANCET (2004)
Investigation of cytokine (tumor necrosis factor-alpha, interleukin-6, interleukin-10) concentrations in the cerebrospinal fluid of female patients with multiple sclerosis and systemic lupus erythematosus
K Baraczka et al.
EUROPEAN JOURNAL OF NEUROLOGY (2004)
Divergent pro- and Antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation
CA Murphy et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice
S Nakae et al.
JOURNAL OF IMMUNOLOGY (2003)
Macrophage inflammatory protein-1
P Menten et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2002)
A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica
CF Lucchinetti et al.
BRAIN (2002)
Chemokines CXCL10 and CCL2: differential involvement in intrathecal inflammation in multiple sclerosis
TL Sorensen et al.
EUROPEAN JOURNAL OF NEUROLOGY (2001)
Macrophage inflammatory protein-1α (MIP-1α), MIP-1β, and RANTES mRNA semiquantification and protein expression in active demyelinating multiple sclerosis (MS) lesions
LA Boven et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2000)
High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism
N Ziolkowska et al.
JOURNAL OF IMMUNOLOGY (2000)
分享论文
